Article
Study of autoantibodies in patients with keratoconjunctivitis sicca infected by the human T cell lymphotropic virus type 1.
Registro en:
FERRAZ-CHAOUI, A. K. et al. Study of autoantibodies in patients with keratoconjunctivitis sicca infected by the human T cell lymphotropic virus type 1. Rheumatology International, v. 30, n. 6, p. 775-778, 2010.
1437-160X
10.1007/s00296-009-1066-5
Autor
Chaoui, Ana Karina Ferraz
Atta, Ajax Mercês
Atta, Maria Luiza Brito de Sousa
Castro Filho, Bernardo Galvão
Santiago, Mittermayer Barreto
Resumen
Human T cell lymphotropic virus type 1
(HTLV-1) is endemic in many regions of the world, including
Brazil, and has been associated to several immunological
manifestations such as arthritis, uveitis, dermatitis and
Sjögren’s syndrome. This study was intended to evaluate
the frequency of autoantibodies in patients infected with
HTLV-1 and manifesting keratoconjunctivitis sicca (KCS).
HTLV-1 patients with KCS, enrolled in a reference ambulatory
of the city of Salvador, were tested for autoantibodies
such as antinuclear antibodies, rheumatoid factor, anti-
SSA/Ro and anti-SSB/La. Two comparison groups were
also included: (a) HTLV-1 patients without KCS and (b)
seronegative patients with KCS. Correlation of proviral
load (PVL) in HTLV-1 patients with presence or absence of
KCS was also assessed. No autoantibodies were detected in
HTLV-1 patients with KCS. The PVL of HTLV-1 patients
was higher in patients with KCS without other clinical
manifestations customarily associated to HTLV-1. In conclusion,
in this study, no changes were observed in humoral
immunity concerning production of certain autoantibodies
in HTLV-1-infected patients with KCS, which suggests that
other mechanisms may be involved in the pathogenesis of
this manifestation. Additionally, PVL may be a marker of
KCS development in these patients.